4.6 Article

Immunogenomic Biomarkers and Validation in Lynch Syndrome

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biochemistry & Molecular Biology

Neoantigens: promising targets for cancer therapy

Na Xie et al.

Summary: Recent advances in neoantigen research have accelerated the development and regulatory approval of tumor immunotherapies, providing emerging targets for personalized cancer immunotherapies and potential predictors for tumor survival prognosis and immune checkpoint blockade responses.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2023)

Editorial Material Gastroenterology & Hepatology

Broadening our Understanding of the Immune Landscape in Lynch Syndrome

Sonia S. Kupfer

GASTROENTEROLOGY (2022)

Review Biochemistry & Molecular Biology

Novel Diagnostic Biomarkers in Colorectal Cancer

Aneta L. Zygulska et al.

Summary: Colorectal cancer is a leading cause of cancer death worldwide, and early diagnosis is crucial for improving survival rates. Current diagnostic methods have suboptimal accuracy, while new molecular noninvasive tests based on CRC alterations are more sensitive and specific. Identifying ideal diagnostic biomarkers remains a challenge.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Gastroenterology & Hepatology

The Different Immune Profiles of Normal Colonic Mucosa in Cancer-Free Lynch Syndrome Carriers and Lynch Syndrome Colorectal Cancer Patients

Lena Bohaumilitzky et al.

Summary: The immune infiltrate in tumor-distant normal colorectal mucosa from individuals with Lynch syndrome (LS) was assessed. It was found that LS carriers show elevated mucosal T-cell infiltration even in the absence of cancer, and this immune profile may impact tumor risk in LS carriers.

GASTROENTEROLOGY (2022)

Article Oncology

Development and evaluation of a colorectal cancer screening method using machine learning-based gut microbiota analysis

Yusuke Konishi et al.

Summary: Accumulating evidence suggests a link between gut microbiota and colorectal cancer (CRC). Machine learning-based analysis of gut bacterial DNA data has been used to develop CRC diagnostic models. However, most studies have small sample sizes and lack independent validation, leading to potential overfitting. In this study, a new machine learning-based CRC diagnostic model was established and validated using independent test datasets, showing promising diagnostic accuracy for both early and advanced stage CRC patients.

CANCER MEDICINE (2022)

Review Oncology

Colorectal Cancer Diagnosis: The Obstacles We Face in Determining a Non-Invasive Test and Current Advances in Biomarker Detection

Faddy Kamel et al.

Summary: Colorectal cancer (CRC) is a commonly occurring cancer that originates from adenomatous polyps. Current detection methods, such as colonoscopy, are invasive and uncomfortable. While some molecular biomarkers have been approved for use, the development of non-invasive and highly specific biomarkers for early detection and screening is urgently needed. This review evaluates the current methods and availability of biomarkers, and discusses the potential of transcriptome analysis in discovering differential gene expression in CRC.

CANCERS (2022)

Review Oncology

Vaccines for immunoprevention of DNA mismatch repair deficient cancers

Alejandro Hernandez-Sanchez et al.

Summary: The development of cancer vaccines was initially inspired by the identification of tumor-antigen specific immune responses, but challenges such as weak immunogenicity and mutational heterogeneity have limited success. Predictable mutational neoantigens, particularly in DNA mismatch repair-deficient cancers, have renewed interest in cancer vaccines. Lynch syndrome represents a high-risk population for the potential development of a preventive cancer vaccine due to the predictability of frameshift peptide neoantigens.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)

Article Oncology

Methylated Septin9 (mSEPT9): A Promising Blood-Based Biomarker for the Detection and Screening of Early-Onset Colorectal Cancer

Holli A. Loomans-Kropp et al.

Summary: mSEPT9 is a sensitive and specific biomarker for the detection of early-onset colorectal cancer (EOCRC) according to this study. The study found that the detection rate of mSEPT9 was significantly higher in EOCRC cases compared to healthy controls, both under and over 50 years old. The cfDNA level of mSEPT9 was also found to be an independent predictor of survival.

CANCER RESEARCH COMMUNICATIONS (2022)

Review Medicine, Research & Experimental

Fit-for-Purpose Biometric Monitoring Technologies: Leveraging the Laboratory Biomarker Experience

Alan Godfrey et al.

Summary: Biometric monitoring technologies (BioMeTs) and laboratory biomarkers share common features but also have unique characteristics that require bench and human experimentation testing phases. Digitally measured biomarkers require prospective data collection for analytical validation and lack widely accepted performance characteristics, necessitating standardized evaluation methods.

CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2021)

Review Oncology

Recent advances in Lynch syndrome

Xi Li et al.

Summary: Lynch syndrome is a common hereditary cancer syndrome characterized by mutations in DNA mismatch repair genes, with colorectal cancer and endometrial cancer being the most common types of cancer associated with this syndrome. Recent advancements have improved our understanding of the disease and have led to more efficient diagnostic and treatment strategies.

EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Review Genetics & Heredity

Liquid Biopsies: Applications for Cancer Diagnosis and Monitoring

Ivana Martins et al.

Summary: Liquid biopsies are a revolutionary approach for cancer management as they can provide a more comprehensive characterization of tumor profiles through the detection of circulating tumor-derived components in biofluids. They have the potential to assist in diagnosis, prognosis, treatment selection, as well as monitoring disease evolution and treatment response in real-time. Despite their value in oncology, some limitations still need to be addressed for their routine clinical implementation.
Review Immunology

Lynch Syndrome and MSI-H Cancers: From Mechanisms to Off-The-Shelf Cancer Vaccines

Vladimir Roudko et al.

Summary: Defective DNA mismatch repair is associated with various cancer types, including Lynch syndrome which increases the risk of malignancy. MSI-H tumors can be treated with checkpoint inhibitors, but the response rates are not high.

FRONTIERS IN IMMUNOLOGY (2021)

Article Immunology

An Integrated Genomic, Proteomic, and Immunopeptidomic Approach to Discover Treatment-Induced Neoantigens

Niclas Olsson et al.

Summary: The study investigated how IFN-gamma alters antigen presentation using a human lymphoma cell line GRANTA-519, indicating that IFN-gamma may reshape antigen repertoires by altering the identity and abundance of tumor cells' antigens.

FRONTIERS IN IMMUNOLOGY (2021)

Editorial Material Oncology

A step closer to a personalised approach for Lynch syndrome

Veroushka Ballester

LANCET ONCOLOGY (2021)

Article Oncology

Variation in the risk of colorectal cancer in families with Lynch syndrome: a retrospective cohort study

Mark A. Jenkins

Summary: The study identified significant familial risk factors affecting colorectal cancer risk for Lynch syndrome carriers, resulting in a wide variation in risk between carriers of the same gene. This highlights the importance of personalized risk assessments for precision prevention and early detection of colorectal cancer in individuals with Lynch syndrome.

LANCET ONCOLOGY (2021)

Review Oncology

Immunology of Lynch Syndrome

Danielle M. Pastor et al.

Summary: The review provides a comprehensive assessment of the immunologic aspects of Lynch syndrome pathogenesis, focusing on the immunogenic properties of Lynch syndrome polyps and associated cancers, as well as potential immune interventions. The rich immune microenvironment of Lynch syndrome lesions offers opportunities for immune-mediating agents to enhance host immune responses and reduce immunosuppressive entities, which can be utilized in prevention and treatment trials for patients with Lynch syndrome polyps and associated cancers.

CURRENT ONCOLOGY REPORTS (2021)

Article Medicine, General & Internal

Systemic immune-inflammation index is a promising non-invasive biomarker for predicting the survival of urinary system cancers: a systematic review and meta-analysis

Xing Li et al.

Summary: This meta-analysis demonstrates that a high pre-treatment SII is associated with poor prognosis in patients with urinary system cancer, and may be linked to unfavorable pathological characteristics.

ANNALS OF MEDICINE (2021)

Review Oncology

Molecular pathology of Lynch syndrome

Guia Cerretelli et al.

JOURNAL OF PATHOLOGY (2020)

Review Immunology

The Landscape of Tumor-Specific Antigens in Colorectal Cancer

Nurul Ainaa Adilah Rus Bakarurraini et al.

VACCINES (2020)

Review Immunology

Inflammation and Cancer: Triggers, Mechanisms, and Consequences

Florian R. Greten et al.

IMMUNITY (2019)

Review Oncology

Tumor neoantigens: from basic research to clinical applications

Tao Jiang et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)

Review Oncology

Recent advances in Lynch syndrome

Leah H. Biller et al.

FAMILIAL CANCER (2019)

Article Radiology, Nuclear Medicine & Medical Imaging

Prostate Cancer and the Evolving Role of Biomarkers in Screening and Diagnosis

Joseph F. Rodriguez et al.

RADIOLOGIC CLINICS OF NORTH AMERICA (2018)

Review Gastroenterology & Hepatology

Systematic review of blood diagnostic markers in colorectal cancer

Stella Nikolaou et al.

TECHNIQUES IN COLOPROCTOLOGY (2018)

Review Biochemistry & Molecular Biology

CD4 and CD8 T lymphocyte interplay in controlling tumor growth

Dmitrij Ostroumov et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2018)

Article Oncology

Prevalence and Penetrance of Major Genes and Polygenes for Colorectal Cancer

Aung Ko Win et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2017)

Review Immunology

Genetically Modified T-Cell-Based Adoptive Immunotherapy in Hematological Malignancies

Baixin Ye et al.

JOURNAL OF IMMUNOLOGY RESEARCH (2017)

Article Gastroenterology & Hepatology

Fecal immunological blood test is more appealing than the guaiac-based test for colorectal cancer screening

Fanny Le Pimpec et al.

DIGESTIVE AND LIVER DISEASE (2017)

Review Oncology

Targeting neoantigens to augment antitumour immunity

Mark Yarchoan et al.

NATURE REVIEWS CANCER (2017)

Review Oncology

The Immune Biology of Microsatellite-Unstable Cancer

Matthias Kloor et al.

TRENDS IN CANCER (2016)

Review Gastroenterology & Hepatology

ACG Clinical Guideline: Genetic Testing and Management of Hereditary Gastrointestinal Cancer Syndromes

Sapna Syngal et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)

Article Oncology

Biomarker: Predictive or Prognostic?

Karla V. Ballman

JOURNAL OF CLINICAL ONCOLOGY (2015)

News Item Oncology

CA-125 blood test in early detection of ovarian cancer

Talha Khan Burki

LANCET ONCOLOGY (2015)

Article Oncology

Fecal DNA testing for colorectal cancer screening: molecular targets and perspectives

Amaninder Dhaliwal et al.

WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2015)

Review Oncology

Biomarker validation and testing

Daniel F. Hayes

MOLECULAR ONCOLOGY (2015)

Review Oncology

Milestones of Lynch syndrome: 1895-2015

Henry T. Lynch et al.

NATURE REVIEWS CANCER (2015)

Article Medicine, General & Internal

Colorectal cancer

Hermann Brenner et al.

LANCET (2014)

Review Oncology

Clinical relevance of circulating cell-free microRNAs in cancer

Heidi Schwarzenbach et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2014)

Article Oncology

Towards a vaccine to prevent cancer in Lynch syndrome patients

Magnus von Knebel Doeberitz et al.

FAMILIAL CANCER (2013)

Review Oncology

Immune responses to cancer: are they potential biomarkers of prognosis?

Theresa L. Whiteside

FRONTIERS IN ONCOLOGY (2013)

Article Medicine, General & Internal

Identification of Lynch Syndrome Among Patients With Colorectal Cancer

Leticia Moreira et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)

Article Gastroenterology & Hepatology

Immune response against frameshift-induced neopeptides in HNPCC patients and healthy HNPCC mutation carriers

Yvette Schwitalle et al.

GASTROENTEROLOGY (2008)